magNews

Corporate Industry Technology Medical Updates

Redefining New Boundaries in Delivering Patient Care

magAssist Recognized in 2024 VENTURE50 Awards

MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China

MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held

Corporate
Redefining New Boundaries in Delivering Patient Care 2025-01-24
Corporate
magAssist Recognized in 2024 VENTURE50 Awards 2025-01-09
Corporate
magAssist was included in the catalogue of "Advantageous Enterprises in the Fourth Batch of Intellectual Property Strong Companies Cultivation Project in Suzhou City". 2024-12-20
Corporate
MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China 2024-06-28
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held 2024-06-24
Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD 2024-05-14
Corporate
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-09-05
Corporate
magAssist ECMO approved in the Transformation of Scientific and Technological Achievements Special Fund 2023-08-28
Corporate
magAssist Attains Recognition as the Most Innovative Medical Device Product of 2023 2023-08-21
Corporate
magAssist's NyokAssist™ granted Designation by the FDA as a Breakthrough Device 2023-08-17

Tags： Innovation, Application, Extra-VAD, U.S. FDA, Interventional Ventricular Assist Device, Breakthrough Device, VENTURE50, Awards, Healthcare, Difference,